ROSENDALE MARTIN P 4
4 · CYTOMEDIX INC · Filed Oct 21, 2010
Insider Transaction Report
Form 4
ROSENDALE MARTIN P
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Other
Common Stock
2010-10-15+1,079→ 70,573 total
Footnotes (1)
- [F1]Received pursuant to a stock dividend on the Company's outstanding Series D Convertible Preferred Stock.